Seth Ettenberg | BiotechTV

top of page

BlueRock’s CEO on the Parkinson’s cell therapy data that was presented today at #MDSCongress

Seth Ettenberg describes safety, imaging, and efficacy takeaways from the 12-patient study.

Company News

Aug 28, 2023

Using a cell therapy as a potential treatment for Parkinson’s with BlueRock's CEO

CEO Seth Ettenberg explains how BlueRock is using pluripotent stems cells to try to restore dopamine production in Parkinson’s patients.

Company News

Jun 28, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

BlueRock’s CEO on the Parkinson’s cell therapy data that was presented today at #MDSCongress

Using a cell therapy as a potential treatment for Parkinson’s with BlueRock's CEO

Follow BiotechTV

Sponsors

Sponsor Spotlight